Integrated BioPharma dismisses Friedman LLP and appoints Marcum LLP as auditor after merger

INTEGRATED BIOPHARMA INC

Friedman LLP combined with Marcum LLP effective September 1, 2022, then operated separately for Integrated BioPharma.
On October 21, 2022, the Audit Committee ratified the dismissal of Friedman and engagement of Marcum.
No disagreements or reportable events occurred in the two most recent fiscal years or subsequent interim period.
Friedman's audit reports for FY2022 and FY2021 were unqualified and not modified as to uncertainty or scope.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.